Today, the All-Party Parliamentary Group on Cancer published an inquiry into the England Cancer Strategy a year on from its publication. Below is Pancreatic Cancer UK’s response.
Commenting on the inquiry, ‘Progress into the implementation of the England Cancer Strategy: One year on’, Preth Rao, Head of Policy and Campaigns at Pancreatic Cancer UK, said:
“We are glad to see the APPG on Cancer calling for the Government to clarify the amount of funding to be dedicated to improving patients’ lives through the England Cancer Strategy, and the vital importance of hearing patients’ voices as it is rolled out. However, we are still very concerned that the strategy doesn’t show how it will tackle improving survival rates for cancers like pancreatic cancer, with the lowest survival rates. Tragically, just five per cent of people with the disease survive for five years after diagnosis, and survival has barely improved since the 1970s. For too long, pancreatic cancer has been sidelined and that’s why we must urgently bring it into the spotlight by increasing investment in research, care and new treatments.”